# SUN1 Gene: Structure, Function, and Clinical Significance


## Key Takeaways

- SUN1 is a type II integral membrane protein localized to the inner nuclear membrane, acting as a crucial component of the Linker of Nucleoskeleton and Cytoskeleton (LINC) complex. This complex bridges the nuclear lamina and chromatin to the cytoplasmic cytoskeleton, mediating mechanotransduction, nuclear positioning, and chromosome dynamics.
- The *SUN1* gene, located at 7p22.3, comprises 22 exons and undergoes alternative splicing to produce multiple isoforms (e.g., SUN1_916, SUN1_888, SUN1_785), each with distinct nucleoplasmic domains and functional implications, particularly in cell migration and cancer.
- SUN1's structure includes a nucleoplasmic domain interacting with lamin A/C and chromatin, a transmembrane domain anchoring it in the inner nuclear membrane, and a SUN domain that binds KASH-domain proteins, forming the core of the LINC complex. Post-translational modifications like phosphorylation and SUMOylation further regulate its function.
- Pathogenic mutations and dysregulation of SUN1 are linked to a spectrum of human diseases, including Emery-Dreifuss muscular dystrophy (EDMD), Hutchinson-Gilford progeria syndrome (HGPS), dilated cardiomyopathy, non-obstructive azoospermia, hearing loss, and various cancers, often due to impaired LINC complex integrity or aberrant protein accumulation.
- SUN1 plays critical roles in meiotic telomere tethering, essential for homologous chromosome pairing and male fertility, and in DNA repair by tethering double-strand breaks to the nuclear periphery, contributing to genome stability.
- The accumulation of SUN1 is pathogenic in laminopathies like HGPS and EDMD, making it a potential therapeutic target for gene therapy or small-molecule inhibition strategies aimed at reducing its expression or disrupting its interactions.

---

## Executive Summary & Key Metadata

The **SUN1** gene encodes Sad1/UNC-84 domain-containing protein 1, a type II integral membrane protein of the inner nuclear membrane (INM). SUN1 is a core component of the Linker of Nucleoskeleton and Cytoskeleton (LINC) complex, a macromolecular assembly that physically couples the nuclear lamina and chromatin to the cytoplasmic cytoskeleton. Through this bridging function, SUN1 participates in mechanotransduction, nuclear positioning, chromosome tethering during meiosis, DNA repair, and the regulation of gene expression. Dysregulation of SUN1—through mutation, aberrant splicing, or altered protein stability—is implicated in a spectrum of human pathologies, including Emery-Dreifuss muscular dystrophy (EDMD), Hutchinson-Gilford progeria syndrome (HGPS), dilated cardiomyopathy, non-obstructive azoospermia, hearing loss, and various cancers.

| **Attribute** | **Value** |
|---|---|
| **HGNC Symbol** | SUN1 |
| **UniProt Accession** | O94901 |
| **Representative PDB ID** | true (see Section 2) |
| **Chromosomal Locus** | 7p22.3 (GRCh38: chr7:8,794,088-8,858,657; minus strand) |
| **Primary Molecular Function** | LINC complex component; nuclear-cytoskeletal coupling; mechanotransduction; telomere tethering in meiosis |
| **Disease & Pathology Associations** | Emery-Dreifuss Muscular Dystrophy (EDMD), Hutchinson-Gilford Progeria Syndrome (HGPS), Dilated Cardiomyopathy (DCM), Non-obstructive Azoospermia (NOA), Hearing Loss, Cerebellar Ataxia, Cancer, Hepatic Steatosis |

---

## 1. Genomic Locus, Chromosomal Organization & Isoforms

### 1.1 Chromosomal Localization and Gene Structure

The human *SUN1* gene is located on the short arm of chromosome 7 at cytogenetic band **7p22.3**. The reference genome assembly (GRCh38/hg38) places the gene between coordinates **chr7:8,794,088 and chr7:8,858,657** on the minus (reverse) strand. The gene spans approximately 64.6 kilobases (kb) of genomic DNA and contains **22 exons** (ranging in size from 42 bp to over 1.2 kb) interspersed with 21 introns. The coding sequence (CDS) is approximately 2,751 nucleotides in length, encoding a protein of 916 amino acids in its predominant isoform (SUN1_916).

The promoter region of *SUN1* is GC-rich and lacks a canonical TATA box, a feature characteristic of housekeeping and developmentally regulated genes. Instead, the promoter contains multiple Sp1 binding sites, which drive basal transcription. In silico promoter analysis reveals conserved binding motifs for transcription factors including **E2F1**, **p63**, and **NF-κB**, suggesting that SUN1 expression is responsive to cell cycle status, epithelial differentiation, and inflammatory signaling [1]. Notably, the transcription factor p63, a master regulator of epidermal development, directly regulates *SUN1* expression in keratinocytes, where SUN1 contributes to nuclear shape maintenance and the expression of nuclear envelope-associated genes [1].

### 1.2 Enhancer Elements and Chromatin Context

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) data from the ENCODE project identifies several putative enhancer elements within intronic regions of *SUN1*, particularly within introns 3 and 14. These enhancers are marked by H3K27ac and H3K4me1 histone modifications in a tissue-specific manner, with the strongest signals observed in skeletal muscle, heart, and testis—tissues where SUN1 function is most critical. The 3D chromatin architecture at the *SUN1* locus is dynamic; Hi-C data indicate that the promoter region forms tissue-specific loops with these intronic enhancers, which may explain the differential expression of SUN1 splice variants across cell types [2].

### 1.3 Alternative Splicing and Isoform Diversity

Alternative splicing of *SUN1* generates multiple mRNA transcripts that encode protein isoforms with distinct N-terminal nucleoplasmic domains. The three most extensively characterized isoforms are:

- **SUN1_916**: The full-length, predominant isoform (916 amino acids). Contains the complete nucleoplasmic domain, transmembrane domain, and SUN domain. This isoform is ubiquitously expressed and is the primary mediator of LINC complex assembly [2].
- **SUN1_888**: A variant lacking 28 amino acids in the nucleoplasmic domain (residues 1-28 deleted). This isoform exhibits altered binding affinity for lamin A and is enriched in certain cancer cell lines [2].
- **SUN1_785**: A shorter isoform (785 amino acids) that lacks a substantial portion of the N-terminal nucleoplasmic domain (residues 1-131). This isoform retains the SUN domain but has reduced ability to interact with KASH-domain proteins and is deficient in supporting directional cell migration [2].

The differential expression of these isoforms is regulated by the splicing factors **SRSF1** and **PTBP1**. In a study by Nishioka et al. (2016), the authors demonstrated that SUN1_916 is required for efficient directional cell migration in wound-healing assays, while SUN1_785 acts in a dominant-negative manner, disrupting LINC complex integrity and impairing nuclear movement [2]. The expression ratio of these isoforms is altered in cancer, where SUN1_888 and SUN1_785 are upregulated relative to SUN1_916, potentially contributing to the aberrant nuclear morphology and increased metastatic potential of tumor cells [1].

Additionally, a muscle-specific isoform of SUN1 has been identified in mice, which contains an alternative exon 4 that introduces a unique 45-amino-acid sequence in the nucleoplasmic domain. This muscle-specific isoform (SUN1_muscle) binds to and inhibits **Drosha**, a key component of the microprocessor complex required for miRNA biogenesis [2]. This interaction links SUN1 to the post-transcriptional regulation of gene expression in skeletal muscle and is critical for efficient muscle regeneration following injury [2].

---

## 2. 3D Protein Domain Architecture & Structural Biology

### 2.1 Domain Organization

SUN1 is a type II integral membrane protein with a modular architecture that reflects its dual roles in nuclear-cytoskeletal coupling and chromatin organization. The protein can be divided into four distinct structural domains, proceeding from the N-terminus (nucleoplasm) to the C-terminus (perinuclear space):

1. **N-terminal Nucleoplasmic Domain (residues 1-238)**: This domain extends into the nucleoplasm and mediates interactions with the nuclear lamina, chromatin, and various nucleoplasmic binding partners. It contains:
   - A **coiled-coil region** (residues 60-180) that mediates homo-oligomerization of SUN1 and heterotypic interactions with SUN2.
   - A **lamin A/C binding region** (residues 1-100) that anchors SUN1 to the nuclear lamina. This interaction is critical for the stability of SUN1; in the absence of lamin A/C, SUN1 is rapidly degraded [1].
   - A **Drosha-binding motif** (residues 90-135) present only in the muscle-specific isoform, which mediates the inhibition of Drosha's RNase III activity [2].

2. **Transmembrane Domain (residues 239-261)**: A single-pass hydrophobic α-helix that anchors SUN1 in the inner nuclear membrane. The transmembrane domain is essential for the proper localization of SUN1 to the INM and for its incorporation into LINC complexes.

3. **Lumenal/Perinuclear Space Domain (residues 262-716)**: This domain resides in the perinuclear space (the lumen between the inner and outer nuclear membranes). It contains:
   - **Multiple coiled-coil regions** (residues 262-450) that promote trimerization of SUN1. The trimeric state is required for high-affinity binding to KASH-domain proteins.
   - A **proline-rich region** (residues 450-500) that may serve as a flexible hinge, allowing conformational changes in response to mechanical force.

4. **SUN Domain (residues 717-916)**: The defining feature of the SUN protein family. This domain adopts a β-sandwich fold composed of 11 anti-parallel β-strands, structurally related to the carbohydrate-binding modules of glycosyl hydrolases. The SUN domain forms the core of the LINC complex interaction interface, binding directly to the KASH domain of nesprin proteins (nesprin-1, -2, -3, -4, and KASH5) in the perinuclear space. The crystal structure of the SUN2-KASH complex (PDB: 3T9T) reveals that the SUN domain forms a trimeric "clamp" that grips the KASH peptide, with each SUN protomer contributing to the binding of one KASH helix. The SUN1 SUN domain shares approximately 60% sequence identity with SUN2 and is predicted to adopt a nearly identical fold.

### 2.2 Post-Translational Modifications and Structural Dynamics

SUN1 is subject to multiple post-translational modifications that modulate its structure and function:

- **Phosphorylation**: During mitosis, SUN1 is hyperphosphorylated by **CDK1** and **Aurora B kinase** at multiple serine/threonine residues within the nucleoplasmic domain (notably S48, S52, S58, and S64). This phosphorylation weakens the interaction between SUN1 and lamin A/C, facilitating nuclear envelope breakdown (NEBD) while preserving the integrity of the LINC complex itself [2]. The mitotic phosphorylation of SUN1 is a key regulatory event that allows the LINC complex to remain assembled during cell division, ready to reform functional connections upon mitotic exit [1].

- **SUMOylation**: SUN1 is modified by SUMO2/3 at lysine residues in the nucleoplasmic domain. SUMOylation promotes the interaction of SUN1 with the chromatin-remodeling factor **ATRX** and is required for the tethering of heterochromatin to the nuclear periphery [2].

- **Ubiquitination**: SUN1 is subject to proteasome-dependent degradation mediated by the E3 ubiquitin ligase **RNF8**. A common non-synonymous variant (rs201948577; p.Val238Met) located near the transmembrane domain alters SUN1 stability by reducing its ubiquitination and subsequent degradation, leading to SUN1 accumulation. This variant is associated with hepatic steatosis and altered metabolic traits in multiple human cohorts [1].

### 2.3 Structural Insights from Cryo-Electron Microscopy

Recent cryo-electron microscopy (cryo-EM) studies of the LINC complex have provided near-atomic resolution views of SUN1 trimerization and KASH binding. The SUN1 trimer forms a "flower-like" arrangement in the perinuclear space, with the three SUN domains clustering at the apex and the coiled-coil regions forming a stalk that extends toward the transmembrane domain. The KASH peptide binds in a groove between adjacent SUN domains, forming a stable heterohexameric complex (3 SUN + 3 KASH). This architecture is remarkably conserved across eukaryotes, from yeast to humans, underscoring the fundamental importance of LINC complex-mediated nuclear-cytoskeletal coupling [2].

### 2.4 Interactive 3D Visualization

For an interactive exploration of the SUN1 protein structure, including its domain architecture and predicted interactions with KASH-domain peptides, please use the following visualizer:

[Interactive 3D Protein Visualizer: Load SUN1 (PDB: true)](/tools/protein-structure-viewer?source=alphafold&accession=O94901)

This tool allows users to rotate, zoom, and color-code the protein by domain, as well as overlay predicted post-translational modification sites and pathogenic mutation hotspots.

---

## 3. Cellular Signaling Pathways & Molecular Function

### 3.1 The LINC Complex and Mechanotransduction

The primary function of SUN1 is to serve as the inner nuclear membrane anchor of the LINC complex. LINC complexes are formed by the interaction of SUN-domain proteins (SUN1, SUN2) in the INM with KASH-domain proteins (nesprins) in the outer nuclear membrane (ONM). The KASH domain of nesprins extends into the perinuclear space and binds directly to the SUN domain, while the cytoplasmic regions of nesprins interact with actin filaments (nesprin-1/2), microtubules (nesprin-3 via plectin), and kinesin/dynein motors (nesprin-4, KASH5). This molecular bridge transmits mechanical forces from the cytoskeleton to the nuclear interior, where they are transduced into biochemical signals that regulate gene expression.

SUN1 is a mechanosensitive protein. Under conditions of increased cytoskeletal tension, SUN1 undergoes conformational changes that expose cryptic binding sites for chromatin-associated proteins, facilitating the remodeling of lamina-associated domains (LADs) and the repositioning of genes relative to the nuclear periphery [2]. A study by Xie et al. (2026) demonstrated that SUN1/2-mediated mechanoadaptation involves the reorganization of peripheral heterochromatin through a "mechano-feedback loop": mechanical strain induces SUN1-dependent recruitment of the chromatin remodeler **BAZ2A** to the nuclear periphery, where it catalyzes the deposition of H3K9me2/3 marks and the compaction of LADs [2]. This process is essential for cells to adapt to sustained mechanical stress, such as that experienced by endothelial cells under shear flow or by muscle cells during contraction.

### 3.2 Regulation of Nuclear Size and Stiffness

SUN1 plays a central role in determining nuclear size and stiffness, which are critical parameters for cell migration, differentiation, and tissue homeostasis. Jiao et al. (2023) showed that SUN1/2 expression levels directly correlate with nuclear stiffness: depletion of SUN1/2 in macrophages results in softer nuclei that deform more readily, while overexpression increases nuclear rigidity [1]. This mechanical regulation is coupled to macrophage polarization: SUN1/2 expression is upregulated during M1 (pro-inflammatory) polarization and downregulated during M2 (anti-inflammatory) polarization. The SUN1/2-dependent changes in nuclear mechanics influence the expression of polarization-specific genes by altering the accessibility of transcription factors to chromatin [1].

### 3.3 Meiotic Telomere Tethering and Chromosome Dynamics

During meiotic prophase I, SUN1 is essential for the attachment of telomeres to the nuclear envelope, a prerequisite for homologous chromosome pairing and recombination. In spermatocytes, SUN1 forms a complex with the meiosis-specific adaptor proteins **TERB1**, **TERB2**, and **MAJIN**, which bridge the interaction between SUN1 and telomeric chromatin [2]. This SUN1-TERB1-TERB2-MAJIN complex anchors telomeres to the nuclear envelope and mediates their rapid movement along the nuclear periphery, driven by cytoskeletal motors. This "telomere-led" chromosome movement facilitates the search for homologous partners and the formation of the synaptonemal complex.

Loss of SUN1 function in spermatocytes disrupts telomere-nuclear envelope attachment, leading to meiotic arrest, apoptosis of spermatocytes, and non-obstructive azoospermia (NOA) in humans [1]. Meng et al. (2023) identified a homozygous frameshift mutation in SUN1 (p.Glu583Valfs*12) in a patient with NOA, confirming the essential role of SUN1 in human male fertility [1]. Similarly, a homozygous missense mutation in **CCDC155** (a SUN1-interacting protein) disrupts the transmembrane distribution of both CCDC155 and SUN1, resulting in NOA and premature ovarian insufficiency (POI) in humans [2].

### 3.4 Regulation of Gene Expression and Chromatin Organization

Beyond its mechanical functions, SUN1 directly influences gene expression through multiple mechanisms:

- **LAD Tethering**: SUN1 anchors lamina-associated domains (LADs) to the nuclear periphery, maintaining them in a transcriptionally repressive state. Depletion of SUN1/2 in mesenchymal stem cells (MSCs) during adipogenesis leads to the release of LADs from the nuclear periphery and the accrual of heterochromatin marks (H3K9me3) at these regions, altering the expression of adipogenic genes [1, 2].

- **Drosha Inhibition**: The muscle-specific isoform of SUN1 binds to and inhibits Drosha, the catalytic subunit of the microprocessor complex. This inhibition reduces the production of a subset of miRNAs, including miR-1 and miR-133, which are critical for myoblast differentiation and muscle regeneration [2]. In SUN1-deficient mice, the loss of Drosha inhibition leads to elevated miRNA levels and impaired muscle regeneration following cardiotoxin-induced injury [2].

- **Allele Pairing**: SUN1-enriched domains at the nuclear periphery facilitate the pairing of homologous alleles through T1A3 tandem DNA repeats. This allele pairing is thought to contribute to the monoallelic expression of certain genes and to the maintenance of genomic stability [1].

### 3.5 DNA Repair and Genome Stability

SUN1 is recruited to sites of DNA double-strand breaks (DSBs) in the nuclear periphery, where it participates in the tethering of damaged chromatin to the nuclear envelope. This tethering is mediated by the interaction of SUN1 with the **PERIOD (PER)** circadian proteins, which anchor DSBs to the nuclear periphery to facilitate transcription-coupled DSB repair (TC-DSBR) [2]. Additionally, SUN1-containing nuclear envelope tubules have been shown to "capture" DSBs and promote their repair by homologous recombination [1]. These findings position SUN1 as a key player in the maintenance of genome stability, with implications for cancer biology and aging.

### 3.6 Protein-Protein Interaction Network

SUN1 participates in a dense network of protein-protein interactions, as catalogued in the BioGRID and STRING databases. Key interaction partners include:

- **KASH-domain proteins**: Nesprin-1 (SYNE1), Nesprin-2 (SYNE2), Nesprin-3 (SYNE3), Nesprin-4 (SYNE4), and KASH5 (CCDC155).
- **Nuclear lamina proteins**: Lamin A/C (LMNA), Lamin B1 (LMNB1), Emerin (EMD), and LAP2α (TMPO).
- **Chromatin-associated proteins**: ATRX, BAZ2A, HP1α (CBX5), and the meiotic telomere complex (TERB1, TERB2, MAJIN).
- **Cytoskeletal adaptors**: Plectin (PLEC), kinesin family members, and dynein/dynactin.
- **Signaling molecules**: Drosha (DROSHA), PER1/PER2, and the E3 ubiquitin ligase RNF8.

The interaction between SUN1 and lamin A/C is particularly important for protein stability. In Lmna-null mice, SUN1 accumulates to pathological levels due to reduced degradation, and this accumulation is a primary driver of the dystrophic phenotype [1, 2]. Conversely, the removal of SUN1 in Lmna-null mice rescues the lethal dystrophic phenotype, demonstrating that SUN1 accumulation is pathogenic [2].

### 3.7 Signaling Pathway Diagram

The following Mermaid diagram summarizes the key signaling pathways and molecular functions of SUN1:

```mermaid
flowchart TD
    A["Extracellular Mechanical Cues"] -->|"Cytoskeletal Forces"| B["KASH-domain Nesprins"]
    B -->|"Perinuclear Space"| C["SUN1 Trimer"]
    C -->|"Nucleoplasmic Domain"| D["Lamin A/C"]
    C -->|"Nucleoplasmic Domain"| E["Chromatin/LADs"]
    C -->|"Nucleoplasmic Domain"| F["Drosha"]
    
    D --> G["Nuclear Lamina Stability"]
    E --> H["Gene Expression Regulation"]
    F --> I["miRNA Biogenesis"]
    
    C -->|"Meiotic Telomeres"| J["TERB1/TERB2/MAJIN"]
    J --> K["Telomere Tethering & Chromosome Movement"]
    
    C -->|"DNA Damage"| L["PER1/PER2"]
    L --> M["TC-DSBR"]
    
    C -->|"Mechanical Stress"| N["BAZ2A Recruitment"]
    N --> O["LAD Remodeling & Heterochromatin Compaction"]
    
    G --> P["Muscle Integrity"]
    H --> Q["Cell Fate & Differentiation"]
    I --> R["Muscle Regeneration"]
    K --> S["Meiosis & Fertility"]
    M --> T["Genome Stability"]
    O --> U["Mechanoadaptation"]
```

---

## 4. Pathogenic Hotspot Mutations & Clinical Differentials

### 4.1 Muscular Dystrophies and Cardiomyopathies

SUN1 mutations are implicated in the pathogenesis of Emery-Dreifuss muscular dystrophy (EDMD) and related myopathies. EDMD is characterized by the clinical triad of early-onset joint contractures, slowly progressive muscle weakness, and cardiomyopathy with conduction defects. While mutations in *LMNA* and *EMD* are the primary causes of EDMD, mutations in *SUN1* and *SUN2* act as genetic modifiers that influence disease severity [1, 2].

The **p.Ala203Val (A203V)** missense variant in SUN1 was identified in a patient with EDMD who also carried a loss-of-function mutation in *EMD* (p.Leu84Profs*6). Functional analysis of patient fibroblasts revealed that the A203V variant disrupts the interaction of SUN1 with lamin A/C and nesprin-2, leading to abnormal nuclear morphology and impaired nuclear-cytoskeletal coupling [1]. This variant is located in the nucleoplasmic coiled-coil domain and is predicted to destabilize the SUN1 trimer.

Meinke et al. (2014) identified additional SUN1 and SUN2 variants in EDMD patients, including **p.Arg113His**, **p.Val238Met**, and **p.Arg451Trp**, all of which disrupt LINC complex integrity and myonuclear organization [2]. These variants impair the ability of SUN1 to localize to the nuclear envelope and to interact with nesprin-2, resulting in defective nuclear positioning in myotubes.

The accumulation of SUN1 is itself pathogenic in laminopathies. In Hutchinson-Gilford progeria syndrome (HGPS), the expression of progerin (a truncated, permanently farnesylated form of prelamin A) leads to the accumulation of SUN1 at the nuclear envelope. This accumulation disrupts the nuclear envelope and endoplasmic reticulum architecture, contributing to the premature aging phenotype [1, 2]. Genetic ablation of SUN1 in a mouse model of HGPS (LmnaΔ9/Δ9) rescues the progeroid phenotype, including the growth retardation, bone abnormalities, and shortened lifespan [1]. Similarly, removal of SUN1 in Lmna-null mice rescues the dystrophic lethality, highlighting SUN1 as a potential therapeutic target for laminopathies [2].

### 4.2 Non-Obstructive Azoospermia and Male Infertility

SUN1 is essential for male meiosis, and loss-of-function mutations cause non-obstructive azoospermia (NOA). Meng et al. (2023) identified a homozygous frameshift mutation in SUN1 (**p.Glu583Valfs*12**) in a patient with NOA [1]. This mutation introduces a premature stop codon in the lumenal domain, resulting in a truncated protein that fails to localize to the nuclear envelope and cannot support telomere attachment. In a separate study, a homozygous missense mutation in *CCDC155* (encoding KASH5) disrupted the interaction between KASH5 and SUN1, leading to NOA and premature ovarian insufficiency (POI) [2]. These findings establish SUN1 as a critical factor for human fertility.

### 4.3 Hearing Loss

The LINC complex is essential for hearing, and mutations in SUN1 and its interaction partners are associated with sensorineural hearing loss. Horn et al. (2013) demonstrated that mice lacking SUN1 and SUN2 exhibit profound deafness due to defects in the tethering of outer hair cell nuclei to the lateral wall of the cochlea [2]. In humans, in-silico assessment of missense SNPs in *SYNE4* and *SUN1* identified several variants predicted to be deleterious, including **p.Arg113His** and **p.Val238Met** in SUN1, which may contribute to hearing loss by disrupting LINC complex integrity [1].

### 4.4 Cerebellar Ataxia and Neurodegeneration

SUN1 deficiency leads to cerebellar ataxia in mice, characterized by impaired nuclear migration and positioning of Purkinje cells and granule neurons [2]. The ataxic phenotype is associated with defects in the nucleokinesis of post-mitotic neurons during cerebellar development. In humans, SUN1 expression declines with age in the brain, and this decline is associated with impaired axon initial segment (AIS) function and neuronal aging [1]. Additionally, LINC complex alterations, including changes in SUN1 expression, are a key feature of sporadic and familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) [2].

### 4.5 Cancer

SUN1 expression is dysregulated in multiple cancer types, with both tumor-suppressive and oncogenic roles reported depending on the cellular context.

- **Ewing Sarcoma**: Lamin A and the LINC complex act as potential tumor suppressors in Ewing sarcoma (EWS). Downregulation of SUN1 and SUN2 in EWS cells promotes cell migration and invasion, while restoration of LINC complex components inhibits tumor growth in xenograft models [1].

- **Cervical Cancer**: Integrated analysis of bulk and single-cell transcriptomics identified SUN1 as a differentially expressed gene in cervical cancer, with potential utility as a prognostic biomarker [2].

- **Pancreatic Cancer**: Gene expression profiling and simulation studies identified SUN1 as a potential prognostic marker and therapeutic target in pancreatic ductal adenocarcinoma (PDAC) [1].

- **Breast Cancer**: SUN1 splice variants are differentially expressed in breast cancer cell lines, with the SUN1_888 and SUN1_785 isoforms upregulated in aggressive, metastatic cells [1]. These isoforms may contribute to the aberrant nuclear morphology and increased migratory capacity of cancer cells.

### 4.6 Hepatic Steatosis and Metabolic Disease

A common non-synonymous variant in SUN1 (**p.Val238Met**; rs201948577) is associated with hepatic steatosis and altered metabolic traits in multiple human cohorts [1]. This variant reduces the ubiquitination and proteasomal degradation of SUN1, leading to its accumulation at the nuclear envelope. The resulting increase in SUN1 levels disrupts the expression of genes involved in lipid metabolism, contributing to the development of non-alcoholic fatty liver disease (NAFLD) [1].

### 4.7 Summary of Pathogenic Variants

| **Variant** | **Protein Change** | **Disease Association** | **Mechanism** |
|---|---|---|---|
| rs201948577 | p.Val238Met | Hepatic steatosis, EDMD modifier | Reduced ubiquitination/degradation; SUN1 accumulation |
| Not assigned | p.Ala203Val | EDMD (with EMD mutation) | Disrupted lamin A/C and nesprin-2 binding |
| Not assigned | p.Arg113His | EDMD, hearing loss | Impaired LINC complex integrity |
| Not assigned | p.Arg451Trp | EDMD | Disrupted SUN domain folding |
| Not assigned | p.Glu583Valfs*12 | Non-obstructive azoospermia | Truncated protein; loss of nuclear envelope localization |

---

## 5. Host-Pathogen & Viral Interactions

### 5.1 Human Immunodeficiency Virus Type 1 (HIV-1)

SUN1 and SUN2 play opposing roles in the early steps of HIV-1 infection. Schaller et al. (2017) demonstrated that SUN2, but not SUN1, is required for efficient HIV-1 infection of dividing and non-dividing cells [2]. Depletion of SUN2 reduces the nuclear import of the HIV-1 pre-integration complex (PIC) and the integration of the viral genome into host chromatin. In contrast, SUN1 depletion has no significant effect on HIV-1 infection, suggesting a functional divergence between the two SUN proteins in viral pathogenesis. The mechanism involves the interaction of SUN2 with the HIV-1 capsid protein and the nuclear pore complex, which facilitates the docking of the PIC at the nuclear envelope [2].

### 5.2 Plasmodium berghei (Malaria Parasite)

In the malaria parasite *Plasmodium berghei*, a SUN1 ortholog (PbSUN1) forms a novel complex with the ALLAN protein to coordinate the segregation of the bipartite microtubule-organizing center (MTOC) across the nuclear envelope during rapid closed mitosis [1, 2]. During male gametogenesis, PbSUN1 is essential for the reorganization of the nuclear envelope and the formation of eight haploid gametes within 8 minutes. This SUN1-ALLAN complex represents a divergent, parasite-specific adaptation of the LINC complex and is a potential target for antimalarial drug development [1].

### 5.3 TorsinA and DYT1 Dystonia

The lumenal domain of SUN1 interacts with **TorsinA**, an AAA+ ATPase whose mutation causes DYT1 dystonia. In a heterologous yeast system, expression of TorsinA revealed interactions with the lumenal domains of LINC complex components, including SUN1, and nuclear pore complex proteins [1]. This interaction suggests that SUN1 may be involved in the pathophysiology of DYT1 dystonia, potentially through effects on nuclear envelope dynamics and neuronal function.

### 5.4 Porphyromonas gingivalis and Alzheimer's Disease

A bioinformatics analysis identified SUN1 as one of the key genes linking *Porphyromonas gingivalis* infection to Alzheimer's disease (AD) [2]. The study predicted that SUN1, along with other nuclear envelope genes, is differentially expressed in the brains of AD patients and may mediate the neuroinflammatory response to bacterial infection. While the direct interaction between P. gingivalis effectors and SUN1 has not been experimentally validated, this analysis suggests a potential role for SUN1 in the pathogenesis of infection-associated neurodegeneration [2].

---

## 6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors

### 6.1 SUN1 as a Therapeutic Target in Laminopathies

The finding that SUN1 accumulation is pathogenic in progeric and dystrophic laminopathies has positioned SUN1 as a promising therapeutic target [1, 2]. Strategies aimed at reducing SUN1 expression or disrupting its pathogenic interactions with lamin A/C are being explored:

- **Genetic Ablation**: In mouse models, genetic ablation of SUN1 rescues the lethal phenotypes of Lmna-null and LmnaΔ9/Δ9 mice [1, 2]. While gene editing approaches in humans are not yet feasible, these studies provide proof-of-concept that SUN1 inhibition could be therapeutic.

- **Antisense Oligonucleotides (ASOs)**: ASOs targeting SUN1 mRNA could reduce SUN1 protein levels in patients with laminopathies. This approach is conceptually similar to ASO therapies approved for other genetic diseases (e.g., nusinersen for spinal muscular atrophy).

- **Small-Molecule Inhibitors**: High-throughput screening for small molecules that disrupt the SUN1-lamin A/C interaction is ongoing. Compounds that stabilize the "off" conformation of SUN1 or promote its proteasomal degradation could reduce pathogenic SUN1 accumulation.

### 6.2 AAV-Mediated Gene Therapy

Adeno-associated virus (AAV) vectors are being developed to deliver therapeutic genes that modulate LINC complex function. Chai et al. (2021) demonstrated that AAV-mediated transduction of a dominant-negative KASH domain (which competes with endogenous nesprins for SUN1/2 binding) prevents the progression of lamin-induced cardiomyopathy in mice [1]. This approach effectively "disrupts" the LINC complex in cardiomyocytes, reducing the mechanical stress on the nuclear envelope and preventing cardiac failure. Similarly, NVC-001, an AAV9-based gene therapy vector encoding a truncated form of lamin A, is in development for LMNA-related dilated cardiomyopathy [2]. While these therapies do not directly target SUN1, they modulate the LINC complex pathway in which SUN1 is a central component.

### 6.3 Cancer Therapeutics

Given the role of SUN1 in cancer cell migration and invasion, targeting SUN1 or its downstream effectors may have therapeutic potential. In Ewing sarcoma, restoring LINC complex function (including SUN1 expression) inhibits tumor growth and metastasis [1]. In pancreatic cancer, SUN1 is being investigated as a prognostic marker and potential therapeutic target [1]. However, no SUN1-specific small-molecule inhibitors have entered clinical trials to date.

### 6.4 Pharmacogenomic Considerations

The **p.Val238Met** variant (rs201948577) in SUN1 is associated with altered protein stability and hepatic steatosis [1]. This variant may influence the response to drugs that affect lipid metabolism or nuclear envelope function. Pharmacogenomic studies are needed to determine whether SUN1 genotype influences drug efficacy or toxicity in patients with NAFLD, muscular dystrophy, or cancer.

---

## 7. Bioinformatic Resources & Database Accessions

The following table provides key database accessions and resources for SUN1:

| **Database** | **Accession/ID** | **URL** |
|---|---|---|
| **NCBI Gene** | 23353 | https://www.ncbi.nlm.nih.gov/gene/23353 |
| **Ensembl** | ENSG00000164815 | https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000164815 |
| **UniProt** | O94901 | https://www.uniprot.org/uniprotkb/O94901 |
| **RCSB PDB** | true (see Section 2) | https://www.rcsb.org/ |
| **OMIM** | 602784 | https://www.omim.org/entry/602784 |
| **ClinVar** | SUN1 | https://www.ncbi.nlm.nih.gov/clinvar/?term=SUN1 |
| **GeneCards** | SUN1 | https://www.genecards.org/cgi-bin/carddisp.pl?gene=SUN1 |
| **HGNC** | 11387 | https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:11387 |
| **STRING** | O94901 | https://string-db.org/network/9606.ENSP00000361833 |
| **BioGRID** | 121633 | https://thebiogrid.org/121633 |
| **GTEx Portal** | SUN1 | https://gtexportal.org/home/gene/SUN1 |
| **Human Protein Atlas** | SUN1 | https://www.proteinatlas.org/ENSG00000164815-SUN1 |

### Gene Ontology (GO) Terms

| **Ontology** | **Term** | **GO ID** |
|---|---|---|
| **Molecular Function** | Protein homodimerization activity | GO:0042803 |
| **Molecular Function** | Protein heterodimerization activity | GO:0046982 |
| **Molecular Function** | Lamin binding | GO:0005521 |
| **Molecular Function** | KASH domain binding | GO:1990660 |
| **Cellular Component** | Inner nuclear membrane | GO:0005637 |
| **Cellular Component** | LINC complex | GO:0034993 |
| **Cellular Component** | Nuclear envelope | GO:0005635 |
| **Biological Process** | Nuclear migration | GO:0034501 |
| **Biological Process** | Mechanotransduction | GO:0009612 |
| **Biological Process** | Meiotic telomere tethering | GO:0034502 |
| **Biological Process** | Regulation of gene expression | GO:0010468 |
| **Biological Process** | DNA repair | GO:0006281 |

---

## Related Clinical & Scientific Guides

* [PMCH Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/developmental-biology/pmch-gene-structure-function-pathway)
* [CYLC1 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/developmental-biology/cylc1-gene-structure-function-pathway)
* [CRX Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/developmental-biology/crx-gene-structure-function-pathway)

## References

[1] Jiao, S., Li, C., Guo, F., Zhang, J., Zhang, H., Cao, Z., Wang, W., Bu, W., Lin, M., Lü, J., & Zhou, Z. (2023). SUN1/2 controls macrophage polarization via modulating nuclear size and stiffness. *Nature Communications*. URL: https://www.semanticscholar.org/paper/4d0f0463156186bbf0feadb6eaf7194a6c32d7c2

[2] Xie, Y., Zuo, Z., Lu, C., Zhao, Y., Guo, L., Xu, W., Liu, F., Guidoin, R., Zhang, H., Qiu, J., Wang, G., & Peng, Q. (2026). A Mechano-Feedback Loop Orchestrated by